title: Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine.
abstract: BACKGROUND
  Free thyroxine (FT4) and free triiodothyronine (FT3) measurements are useful in the diagnosis and treatment of a variety of thyroid disorders. The IFCC Scientific Division established a Working Group to resolve issues of method performance to meet clinical requirements.
  
  
  METHODS
  We compared results for measurement of a panel of single donor sera using clinical laboratory procedures based on equilibrium dialysis-isotope dilution-mass spectrometry (ED-ID-MS) (2 for FT4, 1 for FT3) and immunoassays from 9 manufacturers (15 for FT4, 13 for FT3) to a candidate international conventional reference measurement procedure (cRMP) also based on ED-ID-MS.
  
  
  RESULTS
  For FT4 (FT3), the mean bias of 2 (4) assays was within 10% of the cRMP, whereas for 15 (9) assays, negative biases up to -42% (-30%) were seen; 1 FT3 assay was positively biased by +22%. Recalibration to the cRMP eliminated assay-specific biases; however, sample-related effects remained, as judged from difference plots with biologic total error limits. Correlation coefficients to the cRMPs ranged for FT4 (FT3) from 0.92 to 0.78 (0.88 to 0.30). Within-run and total imprecision ranged for FT4 (FT3) from 1.0% to 11.1% (1.8% to 9.4%) and 1.5% to 14.1% (2.4% to 10.0%), respectively. Approximately half of the manufacturers matched the internal QC targets within approximately 5%; however, within-run instability was observed.
  
  
  CONCLUSIONS
  The study showed that most assays had bias largely correctable by establishing calibration traceability to a cRMP and that the majority performed well. Some assays, however, would benefit from improved precision, within-run stability, and between-run consistency.
authors.affiliation: Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. linda.thienpont@ugent.be
authors.forename: Linda M
authors.initials: LM
authors.lastname: Thienpont
authors.forename: Katleen
authors.initials: K
authors.lastname: Van Uytfanghe
authors.forename: Graham
authors.initials: G
authors.lastname: Beastall
authors.forename: James D
authors.initials: JD
authors.lastname: Faix
authors.forename: Tamio
authors.initials: T
authors.lastname: Ieiri
authors.forename: W Greg
authors.initials: WG
authors.lastname: Miller
authors.forename: Jerald C
authors.initials: JC
authors.lastname: Nelson
authors.forename: Catherine
authors.initials: C
authors.lastname: Ronin
authors.forename: H Alec
authors.initials: HA
authors.lastname: Ross
authors.forename: Jos H
authors.initials: JH
authors.lastname: Thijssen
authors.forename: Brigitte
authors.initials: B
authors.lastname: Toussaint
mesh_terms: D002138:Calibration; D002853:Chromatography, Liquid / Q000379:methods / Q000592:standards; D006801:Humans; D007118:Immunoassay / Q000379:methods / Q000592:standards; D053719:Tandem Mass Spectrometry / Q000379:methods / Q000592:standards; D013960:Thyroid Function Tests / Q000379:methods* / Q000592:standards*; D013974:Thyroxine / Q000097:blood*; D014284:Triiodothyronine / Q000097:blood*
chemical_list: D014284:Triiodothyronine; D013974:Thyroxine